V

Vistin Pharma ASA
OSE:VISTN

Watchlist Manager
Vistin Pharma ASA
OSE:VISTN
Watchlist
Price: 24.2 NOK -2.02% Market Closed
Market Cap: 1.1B NOK
Have any thoughts about
Vistin Pharma ASA?
Write Note

Intrinsic Value

The intrinsic value of one VISTN stock under the Base Case scenario is 23.87 NOK. Compared to the current market price of 24.2 NOK, Vistin Pharma ASA is Overvalued by 1%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VISTN Intrinsic Value
23.87 NOK
Overvaluation 1%
Intrinsic Value
Price
V
Worst Case
Base Case
Best Case

Valuation Backtest
Vistin Pharma ASA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for VISTN cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about VISTN?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Vistin Pharma ASA

Provide an overview of the primary business activities
of Vistin Pharma ASA.

What unique competitive advantages
does Vistin Pharma ASA hold over its rivals?

What risks and challenges
does Vistin Pharma ASA face in the near future?

Summarize the latest earnings call
of Vistin Pharma ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Vistin Pharma ASA.

Provide P/S
for Vistin Pharma ASA.

Provide P/E
for Vistin Pharma ASA.

Provide P/OCF
for Vistin Pharma ASA.

Provide P/FCFE
for Vistin Pharma ASA.

Provide P/B
for Vistin Pharma ASA.

Provide EV/S
for Vistin Pharma ASA.

Provide EV/GP
for Vistin Pharma ASA.

Provide EV/EBITDA
for Vistin Pharma ASA.

Provide EV/EBIT
for Vistin Pharma ASA.

Provide EV/OCF
for Vistin Pharma ASA.

Provide EV/FCFF
for Vistin Pharma ASA.

Provide EV/IC
for Vistin Pharma ASA.

What are the Revenue projections
for Vistin Pharma ASA?

How accurate were the past Revenue estimates
for Vistin Pharma ASA?

What are the Net Income projections
for Vistin Pharma ASA?

How accurate were the past Net Income estimates
for Vistin Pharma ASA?

What are the EPS projections
for Vistin Pharma ASA?

How accurate were the past EPS estimates
for Vistin Pharma ASA?

What are the EBIT projections
for Vistin Pharma ASA?

How accurate were the past EBIT estimates
for Vistin Pharma ASA?

Compare the revenue forecasts
for Vistin Pharma ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Vistin Pharma ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Vistin Pharma ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Vistin Pharma ASA compared to its peers.

Compare the P/E ratios
of Vistin Pharma ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Vistin Pharma ASA with its peers.

Analyze the financial leverage
of Vistin Pharma ASA compared to its main competitors.

Show all profitability ratios
for Vistin Pharma ASA.

Provide ROE
for Vistin Pharma ASA.

Provide ROA
for Vistin Pharma ASA.

Provide ROIC
for Vistin Pharma ASA.

Provide ROCE
for Vistin Pharma ASA.

Provide Gross Margin
for Vistin Pharma ASA.

Provide Operating Margin
for Vistin Pharma ASA.

Provide Net Margin
for Vistin Pharma ASA.

Provide FCF Margin
for Vistin Pharma ASA.

Show all solvency ratios
for Vistin Pharma ASA.

Provide D/E Ratio
for Vistin Pharma ASA.

Provide D/A Ratio
for Vistin Pharma ASA.

Provide Interest Coverage Ratio
for Vistin Pharma ASA.

Provide Altman Z-Score Ratio
for Vistin Pharma ASA.

Provide Quick Ratio
for Vistin Pharma ASA.

Provide Current Ratio
for Vistin Pharma ASA.

Provide Cash Ratio
for Vistin Pharma ASA.

What is the historical Revenue growth
over the last 5 years for Vistin Pharma ASA?

What is the historical Net Income growth
over the last 5 years for Vistin Pharma ASA?

What is the current Free Cash Flow
of Vistin Pharma ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Vistin Pharma ASA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vistin Pharma ASA

Current Assets 154.5m
Cash & Short-Term Investments 11.4m
Receivables 74.3m
Other Current Assets 68.8m
Non-Current Assets 248.5m
Long-Term Investments 11.4m
PP&E 230m
Other Non-Current Assets 7.1m
Current Liabilities 98.7m
Accounts Payable 13.4m
Short-Term Debt 45.8m
Other Current Liabilities 39.4m
Non-Current Liabilities 10.1m
Other Non-Current Liabilities 10.1m
Efficiency

Earnings Waterfall
Vistin Pharma ASA

Revenue
437.7m NOK
Cost of Revenue
-167.3m NOK
Gross Profit
270.4m NOK
Operating Expenses
-189m NOK
Operating Income
81.4m NOK
Other Expenses
-13.1m NOK
Net Income
68.3m NOK

Free Cash Flow Analysis
Vistin Pharma ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

VISTN Profitability Score
Profitability Due Diligence

Vistin Pharma ASA's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
ROE is Increasing
Positive ROE
54/100
Profitability
Score

Vistin Pharma ASA's profitability score is 54/100. The higher the profitability score, the more profitable the company is.

VISTN Solvency Score
Solvency Due Diligence

Vistin Pharma ASA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
69/100
Solvency
Score

Vistin Pharma ASA's solvency score is 69/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VISTN Price Targets Summary
Vistin Pharma ASA

There are no price targets for VISTN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for VISTN?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for VISTN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Vistin Pharma ASA

Country

Norway

Industry

Pharmaceuticals

Market Cap

1.1B NOK

Dividend Yield

7.23%

Description

Vistin Pharma ASA engages in the manufacture and sale of metformin products. The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The company was created as a result of spin-off of Weifa AS. The company specializes in manufacture of Active Pharmaceutical Ingredients (API) and Solid Dosage Forms. Its products portfolio is comprised of Metformin, Pholcodine and Codeine Phosphate, among others. The firm's products are sold domestically and abroad, including markets in Asia, America, Africa and Europe.

Contact

OSLO
Oslo
Ostensjoveien 27
+4735984200.0

IPO

2015-06-10

Employees

-

Officers

CEO, Chief Commercial Officer & Commercial Director
Mr. Magnus Tolleshaug
Chief Financial Officer
Mr. Alexander Karlsen
Chief Operating Officer
Mr. Vegard Heggem
Director of Technical Service & Sales
Eivind Egeli

See Also

Discover More
What is the Intrinsic Value of one VISTN stock?

The intrinsic value of one VISTN stock under the Base Case scenario is 23.87 NOK.

Is VISTN stock undervalued or overvalued?

Compared to the current market price of 24.2 NOK, Vistin Pharma ASA is Overvalued by 1%.

Back to Top